Christopher P Kiritsy's Net Worth

$5.33 Million

Estimate Recalculated Feb 7, 2024 03:59PM EST

Who is Christopher P Kiritsy?

Christopher P Kiritsy has an estimated net worth of $5.33 Million. This is based on reported shares across multiple companies, which include PIERIS PHARMACEUTICALS, INC., HTG MOLECULAR DIAGNOSTICS, INC, and KOS PHARMACEUTICALS INC.

SEC CIK

Christopher P Kiritsy's CIK is 0001261156

Past Insider Trading and Trends

2005 was Christopher P Kiritsy's most active year for acquiring shares with 16 total transactions. Christopher P Kiritsy's most active month to acquire stocks was the month of April. 2005 was Christopher P Kiritsy's most active year for disposing of shares, totalling 24 transactions. Christopher P Kiritsy's most active month to dispose stocks was the month of April. 2005 saw Christopher P Kiritsy paying a total of $1,639,530.00 for 219,000 shares, this is the most they've acquired in one year. In 2005 Christopher P Kiritsy cashed out on 210,500 shares for a total of $5,726,575.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $0.1719

Investor

Christopher P Kiritsy owns 20,000 units of Common Stock which is worth $3,438.00. From 2016 to 2023 Christopher P Kiritsy acquired a total of 20,000 shares in PIERIS PHARMACEUTICALS, INC. at a cost of $41,975.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
+100.00%
10K
$0.85
$8,500.00
20K
May 25
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 25
Form 4/A
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Jan 25
Form 4
+100.00%
5K
$5.11
$25,525.00
10K
Sep 14
Form 4
—
0
—
—
0
Jan 25
Form 4
∞
5K
$1.59
$7,950.00
5K
Apr 21
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Sep 20
Form 3
—
0
—
—
0
No matching records found

HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) Snapshot price: $0.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jan 27
Form 3
—
0
—
—
0
No matching records found

KOS PHARMACEUTICALS INC No price found

Executive VP and CFO

Christopher P Kiritsy owns 3,000 units of Common Stock, $.01 Par Value. From 2003 to 2005 Christopher P Kiritsy acquired a total of 143,000 shares in KOS PHARMACEUTICALS INC at a cost of $1,877,015.00, Christopher also disposed a total of 146,000 shares of KOS PHARMACEUTICALS INC equalling to $7,241,865.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$37.25
-$177,500.00
3K
May 20
Form 4
—
0
$34.75
-$651,520.00
3K
May 16
Form 4
—
0
$32.99
-$100,075.00
3K
May 13
Form 4
—
0
—
—
0
Apr 28
Form 4
—
0
$36.74
-$517,050.00
3K
May 10
Form 4
—
0
$33.91
-$2,640,900.00
3K
May 6 - May 9
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
$24.49
-$69,120.00
2.64K
Sep 15
Form 4
—
0
$25.52
-$87,815.00
2.64K
Aug 23
Form 4
—
0
$23.97
-$375,320.00
2.46K
Mar 12 - Mar 15
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
$21.53
-$164,700.00
2.1K
Aug 27
Form 4
-58.86%
-3.00K
$20.78
-$580,850.00
2.1K
Aug 20 - Aug 22
No matching records found